drugset / Trial / NCT04273334
Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders
NaSingle-groupOpen-labelDiagnostic
Summary
This is an open-label whole-body PET/CT study for investigating the value of 68Ga NEB PET imaging in the diagnosis and evaluation of lymphatic disorders including lymphedema, lymphangioma, lymphangioleiomyomatosis, plastic bronchitis, lymphadenopathy caused by rheumatoid arthritis, etc.
Timeline
- Start
- 2019-10-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-NEB | Diagnostic / imaging agent | 74 mbq | Subcutaneous |
| Subject | 68Ga-NEB | Diagnostic / imaging agent | 111 mbq | Subcutaneous |